首页> 外文学位 >Implementation of an Anti-Platelet Medication Education Process and Post-Discharge Motivational Phone Calls for Post Cardiac Stent Patients
【24h】

Implementation of an Anti-Platelet Medication Education Process and Post-Discharge Motivational Phone Calls for Post Cardiac Stent Patients

机译:心脏支架术后患者的抗血小板药物教育过程和出院后动机电话的实施

获取原文
获取原文并翻译 | 示例

摘要

Premature Clopidogrel discontinuation is the single most crucial culprit of stent thrombosis (40.8%)with a mortality rate >25%. Dual antiplatelet therapy with aspirin and P2Y12 antagonist are a critical component of treatment following PCI to prevent stent thrombosis and related life-threatening complications (Cutlip, 2016). Patients with poor medication adherence to antiplatelet therapy are at high risk for stent thrombosis and recurrent coronary events and often experience the worse outcomes (Palacio et al., 2014).;The aim of the project: Implement a multidisciplinary teaching and post-discharge motivational phone calls to post PCI patients to improve antiplatelet therapy medication adherence and prescription filling behaviors to reduce acute and sub acute stent thrombosis.;Methods: The team enrolled 34 participants who underwent PCI from June 2017 to October 2017. A multidisciplinary teaching implemented to the participants post PCI by an interdisciplinary team along with motivational phone calls within 24 hours and 30-days post discharge to evaluate medication adherence and prescription filling behaviors.;Project Results: A paired sample t-test is used to assess pre and post-intervention showed a significant increase in patient's medication adherence (t= 15.14, p =<0.001) and prescription filling behavior (t=-16.82, p=<0.001), no stent thrombosis reported in 30days, 91.7% of participants filled the prescription on time.;Conclusion: A multidisciplinary teaching and follow-up phone calls after discharge in post PCI patients will significantly improve patient's antiplatelet medication adherence, and prescription filling behaviors consequently reduce acute and sub acute coronary stent thrombosis.
机译:氯吡格雷过早停用是支架血栓形成的最重要原因(40.8%),死亡率> 25%。阿司匹林和P2Y12拮抗剂双重抗血小板治疗是PCI术后预防支架血栓形成和相关危及生命的并发症的关键治疗手段(Cutlip,2016)。药物抗血小板治疗依从性差的患者处于支架血栓形成和冠状动脉再发事件的高风险中,并且往往会出现较差的预后(Palacio等,2014)。该项目的目的:实施多学科教学和出院后激励致电PCI患者以改善抗血小板治疗药物的依从性和处方填充行为,以减少急性和亚急性支架血栓形成。方法:该小组招募了34名从2017年6月至2017年10月接受PCI的参与者。对参与者实施了多学科教学跨学科团队在出院后的24小时和30天内通过PCI进行激励后打电话,并通过激励电话来评估药物的依从性和处方填充行为。项目结果:配对样本t检验用于评估干预前后病人对药物的依从性显着提高(t = 15.14,p = <0.001)和处方行为ior(t = -16.82,p = <0.001),在30天内未报告支架血栓形成,有91.7%的参与者按时填写了处方;结论:PCI后患者出院后进行多学科教学和随访电话将显着改善患者的抗血小板药物依从性,并且处方填充行为可减少急性和亚急性冠状动脉支架血栓形成。

著录项

  • 作者

    Mathew, Elizabeth.;

  • 作者单位

    Brandman University.;

  • 授予单位 Brandman University.;
  • 学科 Health care management.
  • 学位 D.N.P.
  • 年度 2017
  • 页码 52 p.
  • 总页数 52
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:38:59

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号